NGL Fine Chem Ltd

₹ 1,920 -0.64%
May 17 - close price
About

Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products. [1]

Key Points

Product Portfolio
Presently, Veterinary APIs is the main product of the company which account for 89% of its revenues, followed by Veterinary Formulations (5%), Human APIs (2%), Intermediates (2%) & Others (2%). [1] The company has been able to increase its market share in the lower share of its portfolio which has increased to the levels of 50-60%. [2]

  • Market Cap 1,187 Cr.
  • Current Price 1,920
  • High / Low 3,789 / 1,608
  • Stock P/E 23.8
  • Book Value 329
  • Dividend Yield 0.09 %
  • ROCE 34.0 %
  • ROE 27.9 %
  • Face Value 5.00

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.00%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
40.70 37.21 37.42 35.44 42.31 68.34 72.72 71.77 75.86 78.37 81.14 84.06
32.25 32.90 34.19 33.15 28.89 47.94 50.32 50.98 52.29 61.21 68.64 73.50
Operating Profit 8.45 4.31 3.23 2.29 13.42 20.40 22.40 20.79 23.57 17.16 12.50 10.56
OPM % 20.76% 11.58% 8.63% 6.46% 31.72% 29.85% 30.80% 28.97% 31.07% 21.90% 15.41% 12.56%
1.35 0.98 1.19 0.83 2.19 2.76 3.51 2.30 4.55 4.39 3.84 2.98
Interest 0.48 0.58 0.64 0.60 0.60 0.54 0.37 0.33 0.37 0.40 0.42 1.54
Depreciation 1.87 1.97 2.07 2.21 2.10 2.05 2.11 2.08 2.18 2.20 2.42 3.48
Profit before tax 7.45 2.74 1.71 0.31 12.91 20.57 23.43 20.68 25.57 18.95 13.50 8.52
Tax % 30.34% 14.23% 34.50% 164.52% 27.42% 23.19% 24.41% 33.08% 25.22% 26.65% 26.30% 19.60%
Net Profit 5.20 2.35 1.13 -0.20 9.37 15.81 17.71 13.84 19.13 13.91 9.95 6.87
EPS in Rs 8.42 3.80 1.83 -0.32 15.17 25.59 28.67 22.40 30.96 22.52 16.11 11.12

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
153 152 258 318
121 130 178 250
Operating Profit 32 22 80 68
OPM % 21% 14% 31% 21%
4 1 8 11
Interest 3 3 2 2
Depreciation 6 8 8 10
Profit before tax 28 12 78 67
Tax % 27% 31% 27% 25%
Net Profit 20 8 57 50
EPS in Rs 32.58 13.50 91.81 80.77
Dividend Payout % 5% 13% 2% 2%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 28%
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 35%
TTM: -12%
Stock Price CAGR
10 Years: 70%
5 Years: 38%
3 Years: 66%
1 Year: 19%
Return on Equity
10 Years: %
5 Years: %
3 Years: 29%
Last Year: 28%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
3 3 3 3
Reserves 89 96 151 200
Borrowings 27 28 16 27
23 26 37 47
Total Liabilities 142 154 208 277
61 68 64 89
CWIP 0 0 12 6
Investments 9 11 29 29
73 75 102 153
Total Assets 142 154 208 277

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
9 20 27 14
-10 -20 -25 -14
0 -1 -1 -1
Net Cash Flow -1 -0 2 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 79 63 53 74
Inventory Days 106 155 132 139
Days Payable 88 108 86 92
Cash Conversion Cycle 97 110 99 120
Working Capital Days 116 106 83 123
ROCE % 14% 54% 34%

Shareholding Pattern

Numbers in percentages

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
65.45 73.83 73.83 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
34.55 26.17 26.16 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.18

Documents